Edwards pascal precision transcatheter mitral and tricuspid valve repair system receives ce mark

Irvine, calif. , aug. 17, 2022 /prnewswire/ -- edwards lifesciences corporation (nyse: ew), today announced the company's pascal precision transcatheter valve repair system received ce mark for the treatment of mitral and tricuspid regurgitation (mr and tr).
EW Ratings Summary
EW Quant Ranking